EP
ISEE

Eversept Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Eversept Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-350,747
Closed -$7.51M – 82
2022
Q4 		$7.51M Buy
+350,747
New +$7.49M 0.66% 34
2018
Q4 		– Sell
-149,100
Closed -$352K – 70
2018
Q3 		$352K Hold
149,100
– – 0.15% 57
2018
Q2 		$407K Hold
149,100
– – 0.19% 62
2018
Q1 		$409K Hold
149,100
– – 0.19% 52
2017
Q4 		$465K Buy
+149,100
New +$419K 0.27% 38

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Eversept Partners's ISEE Position: Q1 2023 in Review

Eversept Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 350,747 shares — an estimated $7.51M sold.

Eversept Partners first reported a position in ISEE in Q4 2017 and held it in 5 quarters. The position peaked at $7.51M in Q4 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • Eversept Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Eversept Partners sold 350,747 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $7.51M.
  • Eversept Partners first reported a position in IVERIC bio, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
  • Eversept Partners's IVERIC bio, Inc. Common Stock position peaked at $7.51M in Q4 2022.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Eversept Partners's 13F filing for Q1 2023, filed 15 May 2023.